Retroneumoperitoneo secundario a cistitis enfisematosa

Morales-Cárdenas, Adriana; Madrid, Camila Pérez; Fernández, Jessica; Carrillo-Bayona, Jorge Alberto

doi:10.21615/cesmedicina.30.1.11

Cited by 1 publication

(1 citation statement)

References 16 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We report the first case of EC in the setting of severe Crohn’s colitis with no clinical evidence of a UTI. Our patient did not have any of the known risk factors for EC such as diabetes, severe immunodeficiency, systemic infection, hematuria or intra-abdominal instrumentation [ 1 , 3 , 11 ]. While immunological dysfunction is a significant component of Crohn’s disease, it does not make patients immunocompromised and susceptible to infections unless they are on immunosuppressive therapies [ 12 ].…”

Section: Discussionmentioning

confidence: 99%

Emphysematous cystitis as a potential marker of severe Crohn's disease

Hasan

Salh

2022

BMC Gastroenterol

View full text Add to dashboard Cite

Background Emphysematous cystitis (EC) is characterized by the presence of air within the bladder wall, often a complication of urinary tract infection (UTI) by gas-producing organisms. However, EC has also been reported in the setting of infectious colitis suggesting an alternate etiology. We report a rare case of EC in the setting of severe Crohn’s colitis with no clinical evidence of UTI. Case presentation A 43-year old female presented with a 2-month history of bloody diarrhea consisting of 8–12 bowel movements a day, weight loss of 10 kg and peripheral edema. She also had multiple ulcerated lesions on her abdominal wall and in the perianal region. Initial CT scan was significant for pancolitis, anasarca and EC. The follow-up CT cystogram, flexible cystoscopy and pelvic MRI confirmed the diagnosis of EC and ruled out any fistulous tracts in the pelvis including enterovesical/colovesical fistula. The patient did not report any urinary symptoms and the urinalysis was within normal limits. An extensive infectious workup was negative. Despite the paucity of infectious findings, the EC was empirically treated with an intravenous third-generation cephalosporin. Colonoscopy was significant for multiple ulcerated and hyperemic areas with pseudopolyps all throughout the right, transverse and left colon. Biopsies confirmed Crohn’s colitis with no evidence of granulomata or dysplasia. Immunohistochemistry was negative for CMV. The perianal and abdominal wall lesions were suspected to be pyoderma gangrenosum although biopsies were equivocal. The colitis was initially treated with intravenous steroids followed by biologic therapy with Infliximab. Despite appropriate escalation of therapies, the patient developed colonic perforation requiring subtotal colectomy. Conclusion This is a rare case of EC in a patient with severe Crohn’s colitis. There was no evidence of urinary tract infection or fistulising disease. According to our review, this is the first reported incident of EC in a patient with inflammatory bowel disease without any prior intra-abdominal surgeries. While active Crohn’s disease alone is a critical illness, we conclude that concomitant EC may be a poor prognostic factor.

show abstract